Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 to 80

Topical PRP vs PRP injection for smell disorders

Official title: Carrier-Assisted Topical Application Versus Intranasal Injection of Autologous Platelet-Rich Plasma for Olfactory Dysfunction: A Randomized Controlled Trial

Run by Taipei Veterans General Hospital, Taiwan · NCT07151703 · Data updated 2026-11-12

This study tests whether topical PRP applied with a carrier or PRP delivered by injection into the nasal area can improve smell in adults with long-standing olfactory dysfunction.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorTaipei Veterans General Hospital, Taiwan
Government
Locations1 site (Taipei)
StatusRecruiting
StartedSeptember 11, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedOctober 5, 2026
Trial IDNCT07151703 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-80 with hyposmia or anosmia persisting for more than 3 months despite standardized olfactory training.

Probably not a fit

Patients with congenital anosmia, certain neurological or structural brain disorders, or those unable to comply with follow-up may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, Phase 3 trial compares two delivery methods of autologous platelet-rich plasma (PRP) for persistent olfactory dysfunction in adults. Participants receive a single PRP treatment by either intranasal injection or carrier-assisted topical application to the olfactory cleft, followed by three months of daily olfactory training and pre/post smell testing. The study will evaluate changes in olfactory function and patient comfort, along with adverse effects. PRP is prepared on-site to achieve a platelet concentration 2-3 times above baseline. The trial aims to determine which method provides greater efficacy and tolerability in restoring odor function.

Why it matters

Potential benefit: If successful, the study could identify a more effective or comfortable PRP delivery method to improve smell function in patients with chronic olfactory dysfunction.

How similar studies have gone: Prior smaller studies suggest PRP may help olfactory function, but the optimal delivery method remains unestablished, making this trial novel in its direct comparison.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 18 and 80 years, regardless of sex
* Subjective complaint of olfactory dysfunction with confirmed hyposmia or anosmia based on standardized olfactory testing
* History of at least 3 months of prior olfactory training but with persistent olfactory complaints

Exclusion Criteria:

* Congenital anosmia
* Diagnosed neurological or structural brain abnormalities (e.g., brain tumor, major head trauma, stroke) with low likelihood of olfactory recovery
* Inability or unwillingness to comply with study procedures or follow-up assessments

Where it's running

  • Taipei Veterans General Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.